Mgat2 ablation in the myeloid lineage leads to defective glycoantigen T cell responses

Glycobiology

Volumn 24, Issue 3, 2014, Pages 262-271

  Ryan, Sean O ^a   Leal, Sixto M ^b   Abbott, Derek W ^a   Pearlman, Eric ^a,b   Cobb, Brian A ^a  

^a Department of Pathology ^*  (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antigen presentation; CDG IIa; glycoantigen; MHC class II; T lymphocyte

Indexed keywords

ANTIGEN PRESENTATION; CDG-IIA; GLYCOANTIGEN; MHC CLASS II; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; GENE DELETION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MYELOID CELLS; N-ACETYLGLUCOSAMINYLTRANSFERASES; POLYSACCHARIDES; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2;

EID: 84894247278     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwt107     Document Type: Article

References (52)

1. Ackerman ME, Crispin M, Yu X, Baruah K, Boesch AW, Harvey DJ, Dugast AS, Heizen EL, Ercan A, Choi I, et al. 2013. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J Clin Invest. 123:2183-2192.
2. Anthony RM, Kobayashi T, Wermeling F, Ravetch JV. 2011. Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature. 475:110-113.
3. Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. 2008. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science. 320:373-376.
4. Anthony RM, Wermeling F, Ravetch JV. 2012. Novel roles for the IgG Fc glycan. Ann N Y Acad Sci. 1253:170-180.
5. Barbosa JA, Santos-Aguado J, Mentzer SJ, Strominger JL, Burakoff SJ, Biro PA. 1987. Site-directed mutagenesis of class I HLA genes. Role of glycosylation in surface expression and functional recognition. J Exp Med. 166:1329-1350.
6. Brandtzaeg P, Halstensen TS, Huitfeldt HS, Krajci P, Kvale D, Scott H, Thrane PS. 1992. Epithelial expression of HLA, secretory component (poly-Ig receptor), and adhesion molecules in the human alimentary tract. Ann N Y Acad Sci. 664:157-179.
7. Chung DR, Chitnis T, Panzo RJ, Kasper DL, Sayegh MH, Tzianabos AO. 2002. CD4+ T cells regulate surgical and postinfectious adhesion formation. J Exp Med. 195:1471-1478.
8. Chung DR, Kasper DL, Panzo RJ, Chtinis T, Grusby MJ, Sayegh MH, Tzianabos AO. 2003. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol. 170:1958-1963.
9. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8:265-277.
10. Cobb BA, Kasper DL. 2008. Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR. Glycobiology. 18:707-718.
11. Cobb BA, Wang Q, Tzianabos AO, Kasper DL. 2004. Polysaccharide processing and presentation by the MHCII pathway. Cell. 117:677-687.
12. Demetriou M, Granovsky M, Quaggin S, Dennis JW. 2001. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature. 409:733-739.
13. Elliott EA, Drake JR, Amigorena S, Elsemore J, Webster P, Mellman I, Flavell RA. 1994. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J Exp Med. 179:681-694.
14. Germain RN, Rinker AG. 1993. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature. 363:725-728.
15. Goodarzi MT, Turner GA. 1995. Decreased branching, increased fucosylation and changed sialylation of alpha-1-proteinase inhibitor in breast and ovarian cancer. Clin Chim Acta. 236:161-171.
16. Goodarzi MT, Turner GA. 1998. Reproducible and sensitive determination of charged oligosaccharides from haptoglobin by PNGase F digestion and HPAEC/PAD analysis: Glycan composition varies with disease. Glycoconj J. 15:469-475.
17. Gravel P, Walzer C, Aubry C, Balant LP, Yersin B, Hochstrasser DF, Guimon J. 1996. New alterations of serum glycoproteins in alcoholic and cirrhotic patients revealed by high resolution two-dimensional gel electrophoresis. Biochem Biophys Res Commun. 220:78-85.
18. Hart GW. 1982. The role of asparagine-linked oligosaccharides in cellular recognition by thymic lymphocytes. Effects of tunicamycin on the mixed lymphocyte reaction. J Biol Chem. 257:151-158.
19. Jaeken J. 2010. Congenital disorders of glycosylation. Ann N Y Acad Sci. 1214:190-198.
20. Jakubzick C, Bogunovic M, Bonito AJ, Kuan EL, Merad M, Randolph GJ. 2008. Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J Exp Med. 205:2839-2850.
21. Kaneko Y, Nimmerjahn F, Ravetch JV. 2006. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 313:670-673.
22. Kasper DL, Hayes ME, Reinap BG, Craft FO, Onderdonk AB, Polk BF. 1977. Isolation and identification of encapsulated strains of Bacteroides fragilis. J Infect Dis. 136:75-81.
23. Kreisman LS, Cobb BA. 2011. Glycoantigens induce human peripheral Tr1 cell differentiation with gut-homing specialization. J Biol Chem. 286:8810-8818.
24. Kreisman LS, Friedman JH, Neaga A, Cobb BA. 2007. Structure and function relations with a T-cell-activating polysaccharide antigen using circular dichroism. Glycobiology. 17:46-55.
25. Krinos CM, Coyne MJ, Weinacht KG, Tzianabos AO, Kasper DL, Comstock LE. 2001. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature. 414:555-558.
26. Leal SM, Jr, Cowden S, Hsia YC, Ghannoum MA, Momany M, Pearlman E. 2010. Distinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitis. PLoS Pathog. 6:e1000976.
27. Leal SM, Jr, Roy S, Vareechon C, Carrion SD, Clark H, Lopez-Berges MS, Dipietro A, Schrettl M, Beckmann N, Redl B, et al. 2013. Targeting iron acquisition blocks infection with the fungal pathogens Aspergillus fumigatus and Fusarium oxysporum. PLoS Pathog. 9:e1003436.
28. Leal SM, Jr, Vareechon C, Cowden S, Cobb BA, Latge JP, Momany M, Pearlman E. 2012. Fungal antioxidant pathways promote survival against neutrophils during infection. J Clin Invest. 122:2482-2498.
29. Lei W, Jaramillo RJ, Harrod KS. 2007. Transactivation of lung lysozyme expression by Ets family member ESE-1. Am J Physiol Lung Cell Mol Physiol. 293:L1359-L1368.
30. Lewis CJ, Cobb BA. 2010. Carbohydrate oxidation acidifies endosomes, regulating antigen processing and TLR9 signaling. J Immunol. 184: 3789-3800.
31. Mann AC, Record CO, Self CH, Turner GA. 1994. Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: Large changes in glycosylation associated with alcoholic liver disease. Clin Chim Acta. 227:69-78.
32. Ochoa-Reparaz J, Mielcarz DW, Ditrio LE, Burroughs AR, Begum-Haque S, Dasgupta S, Kasper DL, Kasper LH. 2010. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol. 185: 4101-4108.
33. Ochoa-Reparaz J, Mielcarz DW, Wang Y, Begum-Haque S, Dasgupta S, Kasper DL, Kasper LH. 2010. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol. 3:487-495.
34. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. 2011. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 332:974-977.
35. Ryan SO, Bonomo JA, Zhao F, Cobb BA. 2011. MHCII glycosylation modulates Bacteroides fragilis carbohydrate antigen presentation. J Exp Med. 208:1041-1053.
36. Ryan SO, Cobb BA. 2012. Roles for major histocompatibility complex glycosylation in immune function. Semin Immunopathol. 34:425-441.
37. Saldova R, Royle L, Radcliffe CM, Abd Hamid UM, Evans R, Arnold JN, Banks RE, Hutson R, Harvey DJ, Antrobus R, et al. 2007. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology. 17:1344-1356.
38. Strachan DP. 1989. Hay fever, hygiene, and household size. Br Med J. 299:1259-1260.
39. Strachan DP. 2000. Family size, infection and atopy: The first decade of the "hygiene hypothesis". Thorax 55 (Suppl. 1):S2-S10.
40. Thompson S, Dargan E, Griffiths ID, Kelly CA, Turner GA. 1993. The glycosylation of haptoglobin in rheumatoid arthritis. Clin Chim Acta. 220:107-114.
41. Thompson S, Kelly CA, Griffiths ID, Turner GA. 1989. Abnormallyfucosylated serum haptoglobins in patients with inflammatory joint disease. Clin Chim Acta. 184:251-258.
42. Turner GA, Goodarzi MT, Thompson S. 1995. Glycosylation of alpha-1-proteinase inhibitor and haptoglobin in ovarian cancer: Evidence for two different mechanisms. Glycoconj J. 12:211-218.
43. Tzianabos AO, Finberg RW, Wang Y, Chan M, Onderdonk AB, Jennings HJ, Kasper DL. 2000. T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. J Biol Chem. 275:6733-6740.
44. Tzianabos AO, Gibson FC, III, Cisneros RL, Kasper DL. 1998. Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators. J Infect Dis. 178:200-206.
45. Tzianabos AO, Kasper DL, Cisneros RL, Smith RS, Onderdonk AB. 1995. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis. J Clin Invest. 96:2727-2731.
46. Tzianabos AO, Onderdonk AB, Zaleznik DF, Smith RS, Kasper DL. 1994. Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation. Infect Immun. 62:4881-4886.
47. Tzianabos AO, Pantosti A, Baumann H, Brisson JR, Jennings HJ, Kasper DL. 1992. The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides. J Biol Chem. 267:18230-18235.
48. Velez CD, Lewis CJ, Kasper DL, Cobb BA. 2009. Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II-dependent pathway for antigen presentation. Immunology. 127:73-82.
49. Wada Y, Nishikawa A, Okamoto N, Inui K, Tsukamoto H, Okada S, Taniguchi N. 1992. Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem Biophys Res Commun. 189:832-836.
50. Wang Q, McLoughlin RM, Cobb BA, Charrel-Dennis M, Zaleski KJ, Golenbock D, Tzianabos AO, Kasper DL. 2006. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J ExpMed. 203:2853-2863.
51. Wang Y, Tan J, Sutton-Smith M, Ditto D, Panico M, Campbell RM, Varki NM, Long JM, Jaeken J, Levinson SR, et al. 2001. Modeling human congenital disorder of glycosylation type IIa in the mouse: Conservation of asparaginelinked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. Glycobiology. 11:1051-1070.
52. Yamashita K, Ideo H, Ohkura T, Fukushima K, Yuasa I, Ohno K, Takeshita K. 1993. Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. Evidence of asparagine-N-linked oligosaccharide transfer deficiency. J. Biol. Chem. 268:5783-5789.